Institutional
SECTOR GAMMA AS
CIK 0001475373
$423.5M
Reported AUM
42
Positions
Q1 2026
Period
2026-05-07
Filed
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMY | BRISTOL-MYERS SQUIBB CO | $64.82 | -0.05% | 51.55% | 17.37% | $50.2M | 11.86% | — | HELD |
| 2 | MRK | MERCK & CO INC | $130.79 | 0.77% | 68.33% | 97.86% | $31.3M | 7.39% | — | HELD |
| 3 | PFE | PFIZER INC | $25.09 | 0.72% | 13.48% | -29.55% | $30.6M | 7.24% | — | HELD |
| 4 | MDT | MEDTRONIC PLC | $85.02 | -0.81% | -2.60% | -26.16% | $24.3M | 5.74% | — | HELD |
| 5 | INCY | INCYTE CORP | $119.43 | -2.89% | 57.64% | 55.79% | $18.9M | 4.46% | — | HELD |
| 6 | AMGN | AMGEN INC | $382.93 | -1.22% | 34.50% | 99.65% | $16.6M | 3.92% | — | HELD |
| 7 | BIIB | BIOGEN INC | $204.58 | -1.61% | 54.30% | -39.92% | $16.5M | 3.90% | — | HELD |
| 8 | ZBH | ZIMMER BIOMET HOLDINGS INC | $92.78 | -2.30% | 2.77% | -34.12% | $14.1M | 3.33% | — | HELD |
| 9 | BMRN | BIOMARIN PHARMACEUTICAL INC | $59.46 | -1.85% | 2.19% | -29.44% | $13.6M | 3.20% | — | HELD |
| 10 | BDX | BECTON DICKINSON & CO | $164.61 | -0.51% | 22.25% | -6.50% | $13.0M | 3.07% | — | HELD |
| 11 | ELV | ELEVANCE HEALTH INC FORMERLY | $378.48 | 0.55% | 39.92% | 7.81% | $12.9M | 3.04% | — | HELD |
| 12 | IONS | IONIS PHARMACEUTICALS INC | $51.40 | -3.53% | 20.59% | 30.51% | $12.7M | 3.00% | — | HELD |
| 13 | CAH | CARDINAL HEALTH INC | $228.48 | 0.62% | 48.42% | 386.80% | $11.6M | 2.74% | — | HELD |
| 14 | UNH | UNITEDHEALTH GROUP INC | $420.63 | -0.20% | 80.64% | 9.66% | $9.9M | 2.33% | — | HELD |
| 15 | CVS | CVS HEALTH CORP | $105.34 | 0.11% | 73.78% | 43.77% | $9.7M | 2.30% | — | HELD |
| 16 | BRKR | BRUKER CORP | $62.43 | -2.97% | 65.68% | -27.87% | $9.2M | 2.17% | — | HELD |
| 17 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $67.71 | -3.19% | 0.32% | 1.20% | $9.0M | 2.12% | — | HELD |
| 18 | ABT | ABBOTT LABS | $105.32 | -0.27% | -15.36% | -8.15% | $9.0M | 2.12% | — | HELD |
| 19 | GILD | GILEAD SCIENCES INC | $129.90 | -1.05% | 19.01% | 116.49% | $7.4M | 1.75% | — | HELD |
| 20 | LNTH | LANTHEUS HLDGS INC | $100.00 | -0.99% | 41.33% | 278.23% | $7.1M | 1.67% | — | HELD |
| 21 | IQV | IQVIA HLDGS INC | $233.54 | -1.79% | 28.14% | -9.99% | $6.9M | 1.62% | — | HELD |
| 22 | SNDX | SYNDAX PHARMACEUTICALS INC | $18.81 | -3.44% | 90.98% | 8.98% | $6.7M | 1.58% | — | HELD |
| 23 | BIO | BIO RAD LABS INC | $324.01 | -0.83% | 12.21% | -60.32% | $6.6M | 1.56% | — | HELD |
| 24 | QGEN | QIAGEN NV | $41.30 | -0.36% | -16.82% | -25.27% | $6.5M | 1.54% | — | HELD |
| 25 | AVTR | AVANTOR INC | $13.74 | -0.83% | 20.20% | -65.38% | $5.5M | 1.29% | — | HELD |
| 26 | CNC | CENTENE CORP DEL | $61.88 | 1.71% | 135.57% | -3.09% | $5.3M | 1.26% | — | HELD |
| 27 | TNDM | TANDEM DIABETES CARE INC | $18.87 | -0.74% | 22.34% | -83.20% | $5.1M | 1.21% | — | HELD |
| 28 | PTCT | PTC THERAPEUTICS INC | $68.13 | -9.79% | 35.28% | 61.56% | $5.1M | 1.21% | — | HELD |
| 29 | LH | LABCORP HOLDINGS INC | $309.10 | -2.04% | 19.34% | 24.69% | $5.1M | 1.20% | — | HELD |
| 30 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $4.9M | 1.15% | — | HELD |
| 31 | EW | EDWARDS LIFESCIENCES CORP | $85.79 | -1.31% | — | — | $4.8M | 1.14% | — | HELD |
| 32 | DXCM | DEXCOM INC | $82.39 | 10.54% | — | — | $3.5M | 0.83% | — | HELD |
| 33 | CRNX | CRINETICS PHARMACEUTICALS IN | $83.77 | 0.17% | — | — | $3.4M | 0.81% | — | HELD |
| 34 | KURA | KURA ONCOLOGY INC | $8.93 | -4.08% | — | — | $3.3M | 0.79% | — | HELD |
| 35 | HUM | HUMANA INC | $369.20 | 0.69% | — | — | $3.3M | 0.79% | — | HELD |
| 36 | BBIO | BRIDGEBIO PHARMA INC | $79.72 | -2.95% | — | — | $3.3M | 0.78% | — | HELD |
| 37 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $4.05 | -13.75% | — | — | $3.2M | 0.75% | — | HELD |
| 38 | DNLI | DENALI THERAPEUTICS INC | $23.22 | -4.66% | — | — | $3.1M | 0.74% | — | HELD |
| 39 | ARDX | ARDELYX INC | $4.95 | -1.79% | — | — | $3.1M | 0.73% | — | HELD |
| 40 | COGT | COGENT BIOSCIENCES INC | $39.35 | -4.86% | — | — | $3.1M | 0.73% | — | HELD |
| 41 | OGN | ORGANON & CO | $13.56 | 0.04% | — | — | $2.3M | 0.53% | — | HELD |
| 42 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $85.00 | -2.66% | — | — | $1.9M | 0.44% | — | HELD |
Source: SEC EDGAR · accession 0000945621-26-000644. 13F discloses long positions only — shorts, foreign equities, and options are excluded.